The registration, importation and distribution of all heartburn medication containing ranitidine has been suspended in the UAE.
According to the Ministry of Health and Prevention (MoHAP), a circular was issued to health facilities and practitioners informing them about the move.
The decision is based on the recommendations of the US Food and Drug Administration (FDA) and other regulatory bodies regarding a possible contamination of the medicine with an impurity which is classified as potentially carcinogenic.
The Ministry says those wishing to stop taking medicine with ranitidine should consult a healthcare professional for a replacement.

Sheikh Mansour reviews second phase of Agentic AI project
Dubai Humanitarian boosts relief efforts in Nepal
Dubai Metro turns 17
UAE issues statement in response to media speculation
UAE envoy highlights strong relations with Germany ahead of President's state visit
Fourth UAE aid shipment arrives in Nepal
Dubai private schools rank among world's top 10 in PISA 2025
UAE strongly condemns Houthi attacks on Saudi civilian, economic facilities
